This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CannaTech showcases the biggest industry thought leaders, known for their significant and groundbreaking contributions to the global cannabis market in fields such as science, finance, government policy and tech. policy towards marijuana. Where is it all headed?” Cannabis evolution under the Obama Administration.
We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% We had previously blogged on The Stoned Age: What the CBD Craze Means for Employers and Their Substance Abuse Policies , CBD is Everywhere – But Where Does the FDA Stand? ,
Following the recent news of Texan sprinter Sha’Carri Richardson returning a positive test for cannabis, a debate has erupted on the topic of cannabis as a performance-enhancing drug – can the plant enhance agility, strength, and/or speed? Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research.
However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification. The DEA definition of a Schedule 1 substance is : Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse.
Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. A major achievement of the 2018 Farm Bill was that it cleared the way for the Federal Crop Insurance Corporation to offer policies to hemp farmers.
Topical CBD Pain-Relief Receives FDA Product Listing Certification. Elixicure, an over-the-counter (OTC) CBD-infused topical pain-relief cream marketed for treating inflammation, aches, and pains, has received product listing certification from the Food & Drug Administration (FDA). CBD Class Action Litigation.
Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. Last year, the U.S. View original article.
The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. POPLAR will publish original law and policy research. Chloe Reichel: Can you describe the primary goals of POPLAR?
The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. One area that could be quickly improved is in the sourcing of research-grade marijuana.
This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.
Drug policytopics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. The panel would center on the evolution of cannabis policy in the U.S.,
January proved that there’s always a cannabis angle, no matter what the topic of conversation. In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. Several northeastern states tried to coordinate their marijuana policies.
We have noted previously that the federal Drug Enforcement Agency (DEA) recently announced that drugs that include CBD (cannabidiol) with less than 0.1% That laboratory informed plaintiff that it could not run the tests on the Dixie X as the substance was illegal and contained THC levels well over the federal limit as per DEA regulations.
Let’s start in the northeast, where the governors of four states (New York, New Jersey, Connecticut and Pennsylvania) met to discuss coordinating their states’ cannabis policies. Cannabis research was also a big topic. All four are supporters of adult-use legalization. Finally, what on earth is going on in Oklahoma?
Her pro-pot policies would take shape in college during the ’90s and early 2000s. Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . In time, she would help bring a national great debates series to campus.
Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. Ganjapreneur. Marijuana Times.
It has been less than eight years since the DEA, the Criminal Investigation Division of IRS, and the Office of the U.S. We have previously written on this topic. The announcement would have explained the pending criminal investigation relates to public corruption, tax evasion and money laundering. See Reboot in 2020! ,
During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Family physicians have a vested interest in policies that advance and protect the health of their patients and the public. Marijuana Possession for Personal Use. Call to Action.
33%. – Beverages, edibles, topicals. and vapes. 14%. – Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Canadian recreational cannabis. – Dry bud[8]. – – Oils and softgels8. 73%. – Excise taxes.
Beverages, edibles, topicals 7. and vapes. Beverages, edibles, topicals. and vapes. Drug Enforcement Administration (the “DEA”), the U.S. Other revenue adjustments 8. $(3.0). Excise taxes. Medical cannabis and other. – Oils and softgels. Excise taxes. $(1.4). state and federal law to U.S.
The panel covered a wide range of topics local regulators are currently dealing with, including reconciling local and state regulations, enforcement of illicit businesses, license caps, equity and diversity, delivery, onsite consumption, and, of course, taxes. Photo Credit: Kandid Kush. Photo Credit: Kandid Kush. Who is on your team?
Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. Edibles and topicals emerged as the two categories users indicated that were consuming more of post-legalization. . Download : Cannabis Misinformation: What Does the DEA say about Marijuana?
In case you haven’t heard, the Drug Enforcement Administration (DEA) wants to hear from you on marijuana rescheduling. Specifically, DEA invites your comments on its notice of proposed rulemaking (NPRM) to move both marijuana and marijuana extract from schedule I to schedule III of the federal Controlled Substances Act (CSA).
All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Unfortunately, this change in policy has been promised for years and never actually materialized.”.
Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.
The enforcement role moves from DEA to ATF. When it comes to enforcing federal cannabis regulations, the Drug Enforcement Administration (“DEA”) is out and the Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is in (in addition to TTB as the primary overseer). Age limits (21). ” SBA fairness.
(See Thoughts on the Terrible Pageant of Marijuana Rescheduling ) Even if marijuana is moved into Schedule III, it will still be illegal to buy and sell interstate without a DEA license, and state markets won’t fundamentally change. The leading case on this topic is United States v. marijuana operators.
On the other side of the country our nation’s capital has its own ballot initiative on psychedelics, Initiative 81, formally known as the Entheogenic Plant and Fungus Policy Act of 2020. Psilocybin remains a Schedule 1 drug, meaning the DEA says it has a high likelihood of abuse and no accepted medical use – just like marijuana.
A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. There must be a concerted effort by the FDA and DEA to address the public health crisis spawned by the proliferation of unregulated designer drugs being sold under the guise of hemp.
Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. Times (Nov. 11, 2021), [link]. [10]
On October 30, during a friendly as-can-be debate with Senate Majority Leader Chuck Schumer and Republican challenger Joseph Pinion, the SAFE Banking Act was the topic of discussion. The Drug Policy Reform Act. Schumer reassured several times that Congress is “very close” “to introducing and passing the SAFE Banking Act.
The bottom line is that until the DEA, USDA, federal Food and Drug Administration, and state law enforcement agencies figure out what to do about hemp—and don’t hold your breath that this will happen any time soon—hemp transporters and their employees face monumental risks. laws, regulations, and policies everywhere they go.
This stems from the fact that despite the ongoing legalization of both recreational and medical marijuana at the state level, cannabis is still classified as a Schedule I substance by the DEA, along with substances such as heroin, cocaine, opioids and methamphetamine.
Based on our analysis, there are currently around 160 companies selling delta-8 THC products online, with more than 4,200 unique products for sale, including edibles, concentrates, vapes, flower, prerolls, tinctures, topicals and beverages. The second argument is based on a DEA interim final rule on the topic of synthetic THC.
Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid.
Colombia had approved legislation in 2016 that regulates the production, distribution, sale and export of seeds, topicals and other cannabis products, but had prohibited the export of dried cannabis flower up until now, fearing that such a move would allow for the flow of legal cannabis products into the black market.
In response to the 2018 farm bill, the USDA and the DEA have weighed in with interim rules establishing a system for the production of massive amounts of hemp-derived CBD and other cannabinoids. The topical product also contained mostly THC and very little CBD, indicating it was cannabis and not hemp-derived. View original article.
Barr stated, “I am not going to go after companies that have relied on the Cole memorandum,” referring to the 2013 Obama administration policy of not enforcing marijuana prohibition in states where legalization has been established. “To Nevertheless, during his confirmation hearing in January 2019, Attorney General William P. Comm’r (T.C.
Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. And proficiency testing right now, because of the DEA is very limited in what can get sent out.
Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Wasn’t the DEA going to let others grow research-grade cannabis? It tested at only 9% THC. View Bruce Kennedy’s articles.
Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Rather, it was based on a policy that was created in the 1950s, before THC or CBD were isolated and before the endocannabinoid system was discovered. Is THC safe? Yes, cannabis is an extremely safe drug.
Not only does he depict a way forward in progressive politics for a traditionally conservative area, but he also shows that such policies can benefit people from a wide variety of backgrounds. As the last denizen of the “outlaw country” era, Nelson is a figure of a piece of American history that is, unfortunately, long gone.
As I noted, rescheduling cannabis to schedule II or below is a bad idea, because it would subject cannabis to DEA regulations similar to prescription drugs. Anyone familiar with the cannabis industry has heard of section 280E of the Internal Revenue Code, a topic we’ve written about often over the years.
As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content